VETAZINETM CREAM Modern Veterinary Therapeutics, LLC TRIAMCINOLONE ACETONIDE CREAM, USP 0.1%. For Topical Use on Dogs Only CAUTION: Federal law restricts this drug to use by or on the order of a
licensed veterinarian. DESCRIPTION: VETAZINETM Cream (triamcinolone acetonide) provides
1 mg triamcinolone acetonide per gram (0.1%) in a vanishing cream base
containing propylene glycol, emulsifying wax, mineral oil, sorbitol, cetyl
palmitate, sorbic acid, potassium sorbate and purified water. ACTIONS: VETAZINETM Cream contains a corticosteroid that provides
prompt relief of itching, burning, inflamed skin lesions by virtue of its
anti-inflammatory, antipruritic and anti-allergic effects. INDICATIONS: VETAZINETM Cream is indicated for topical treatment
of allergic dermatitis and summer eczema in dogs. CONTRAINDICATIONS: VETAZINETM Cream should not be used
ophthalmically. WARNINGS: VETAZINETM Cream is indicated for use on dogs only. Do
not use VETAZINETM Cream on animals which are raised for food
production. Absorption of triamcinolone acetonide through topical application on the
skin and by licking does occur. Therefore, dogs receiving VETAZINETM
Cream therapy should be observed closely for signs of polydipsia, polyuria
and increased weight gain, particularly when used over large areas or for
extended periods of time. Clinical and experimental data have demonstrated that corticosteroids
administered orally or by injection to animals may induce the first stage of
parturition if used during the last trimester of pregnancy and may precipitate
premature parturition followed by dystocia, fetal death, retained placenta
and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents
during pregnancy have resulted in cleft palate in offspring. Corticosteroids
administered to dogs during pregnancy have also resulted in other congenital
anomalies including deformed forelegs, phocomelia and anasarca. PRECAUTIONS: If local infection exists, suitable concomitant
antimicrobial therapy should be administered. If favorable response does
not occur promptly, application of VETAZINETM Cream should be
discontinued until the infection is adequately controlled by appropriate
measures. Avoid ingestion. Oral or parenteral use of corticosteroids,
depending on dose, duration and specific steroid, may result in inhibition
of endogenous steroid production following drug withdrawal. SIDE EFFECTS: SAP and SGPT (ALT) enzyme elevations, polydipsia
and polyuria have occurred following parenteral or systemic use of synthetic
corticosteroids in dogs. Vomiting and diarrhea (occasionally bloody) have
been observed in dogs. Cushing’s Syndrome in dogs has been reported in association with prolonged
or repeated steroid therapy. DOSAGE AND ADMINISTRATION: Apply VETAZINETM Cream by
rubbing into the affected areas two to four times daily for 4 to 10 days. HOW SUPPLIED: VETAZINETM Cream is supplied in 28.4 & 85.2 gram
tubes. STORAGE: Store at room temperature; avoid freezing. Do not store above
30°C (86°F). ANADA 200-459, Approved by FDA.
Manufactured for:Modern Veterinary Therapeutics, LLCCoral Gables, Florida 33146 - USA
LM3242 PRODUCT BRIEF 6MHz, 750mA Miniature, Adjustable, Step-Down DC-DC Converter with Auto Bypass for RF Power Amplifiers LM3242 PRODUCT BRIEF PRODUCT BRIEF 6MHz, 750mA Miniature, Adjustable, Step-Down DC-DC Converter with Auto Bypass for RF Power Amplifiers General Description Features The LM3242 is a DC-DC converter optimized for powering RFpower amplifiers (PAs) f
The following treatment guidelines are based on the results of clinical studies and are provided for information purposes only. It is the operating ophthalmologist’s responsibility to familiarize themselves with the latest recommended techniques. Almost all patients with abnormally elevated IOP, which The treatment regimen is evolving and protocols vary may benefit from IOP reduction, are sui
VETAZINETM CREAM